Trajenta

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRAJENTA CMI0133-09 Tablets linagliptin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Trajenta. It does not contain all the available information. It does not take the place of talking to your doctor, pharmacist or diabetes educator. All medicines have risks […]

Read more

Coronavirus update: Warning to those living with type 2 diabetes during COVID-19

Type 2 diabetes and obesity are risk factors for COVID-19, leading to increased risk of severe illness in people who develop COVID-19. A condition known as diabetic ketoacidosis can ensue making one’s blood sugar levels dangerously high. READ MORE Dementia care: Having this kind if outlook may increase your risk For those living with type 2 diabetes, being more vulnerable to […]

Read more